What if you'd held PTCT?
A $1,000 investment in PTC Therapeutics, Inc. (PTCT) at the month-end close of 2013-06 would be worth $4,620 at the close of 2026-09 — +362.0% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $6,068.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2013
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2013 | $1,000 | — |
| 2014 | $3,051 | +205.1% |
| 2015 | $1,909 | -37.4% |
| 2016 | $643 | -66.3% |
| 2017 | $983 | +52.9% |
| 2018 | $2,022 | +105.8% |
| 2019 | $2,830 | +39.9% |
| 2020 | $3,596 | +27.1% |
| 2021 | $2,347 | -34.7% |
| 2022 | $2,249 | -4.2% |
| 2023 | $1,624 | -27.8% |
| 2024 | $2,660 | +63.8% |
| 2025 | $4,476 | +68.3% |
| 2026 | $4,084 | -8.8% |
Best and worst month-end to buy
The best single month-end close to have bought PTCT was 2016-07 ($5.97): $1,000 then is $11,608 today. The worst was 2025-11 ($85.99): $1,000 then is $806.
FAQ
What would $1,000 in PTCT be worth today?
A $1,000 investment in PTC Therapeutics, Inc. (PTCT) at the start of 2013 would be worth about $4,620 today, a total return of +362.0%. Dividends are reinvested in these figures.
What were the best and worst years for PTCT?
PTC Therapeutics, Inc. (PTCT)'s strongest calendar year since 2013 was 2014, a +205.1% return — $1,000 held through that year became about $3,051 by year-end. Its weakest year was 2016, at -66.3%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in PTCT have grown?
Investing $100 at the end of every month since 2013-06 would have grown to about $40,621 on $16,000 invested.
Did PTCT beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $6,068. PTCT trailed the S&P 500 by +23.9% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
PTC Therapeutics, Inc. (PTCT) historical total-return data from 2013-06 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.